Editorial / commentary
Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
The New England journal of medicine · 26 Oct 2023
Record
Publication details
- Authors
- Bisson A, Fauchier G, Fauchier L
- Journal
- The New England journal of medicine
- Publication date
- 26 Oct 2023
- Publication type
- Letter; Comment
- Evidence type
- Editorial / commentary
- Relevance classification
- Primary
- PubMed ID
- 37888925
- DOI
- 10.1056/NEJMc2310645
- Language
- eng
- Linked clinical trial
- Not reported
Abstract
Abstract not reported by the source record.
Weekly briefing
The Retatrutide Report
The most important retatrutide clinical trial, research and regulatory developments, once a week.
No spam. Unsubscribe anytime. By subscribing, you agree to receive the Retatrutide Report by email. You can unsubscribe at any time. Privacy Policy.